By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novavax, Inc. 

9920 Belward Campus Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-268-2000 Fax: n/a



Drug Delivery

Company News
Novavax (NVAX) Announces Management Promotion 10/2/2015 7:40:43 AM
Novavax (NVAX) Announces Positive Top-Line Data From RSV F Vaccine Phase I Clinical Trial In Pediatrics 9/30/2015 7:07:58 AM
Novavax (NVAX) To Host 3rd Annual Analyst And Investor Meeting 9/29/2015 7:35:40 AM
Novavax (NVAX) Snags Grant Worth $89 Million from Bill & Melinda Gates Foundation 9/29/2015 5:54:09 AM
Novavax (NVAX)'s RSV Vaccine Protect Infants via Maternal Immunization in Phase II Study 9/29/2015 5:51:54 AM
Novavax (NVAX) To Host 3rd Annual Analyst And Investor Meeting 9/22/2015 10:15:39 AM
Novavax (NVAX) To Present At The Ladenburg Thalmann 2015 Healthcare Conference 9/22/2015 8:37:46 AM
Novavax (NVAX) RSV F Vaccine Is Highly Immunogenic With Robust Transplacental Antibody Transfer In Preclinical Maternal Immunization Model 9/16/2015 8:39:16 AM
Novavax (NVAX) RSV F Vaccine Clinical Trial Data In Women Of Child Bearing Age Published In The Journal Of Infectious Disease 9/11/2015 6:46:31 AM
Novavax (NVAX) To Participate In Multiple Investor Conferences In September 9/3/2015 8:25:39 AM